Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

<< Previous

Bullboard Posts

Next >>

Post by MustangSalleyon Jan 06, 2022 5:49pm

234 Views

Post# 34290917

@Mouth

Just seeking clarification on your comment about $2 base . I think there will new investors to the story and them finding out a few insulin independent patients could be significant . This brings me to another point about IR and getting publicity out for good results .

Seems like Viacycte, Semma always get some much publicity with their results . I think to get new investors interested in the story , IR has to have a wider reach especially in the States .

MS

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec